News
EAU: Focused strategy to encourage timely detection PCa
With a remarkable upturn in prostate cancer mortality, the time has come to encourage earlier detection says EAU Adjunct-Secretary General Prof. Hendrik Van Poppel (BE). “For years, prostate cancer screening was synonymous with overdiagnosis and overtreatment. However, with modern...
Announcement: NIMBUS trial to end in 2020
The EAU Research Foundation’s Randomised Phase III Clinical Trial NIMBUS has stopped recruitment due to the results of a safety analysis. The trial, which ran from 2013 and studied reduced frequency BCG instillations in NMIBC, involved nearly 360 patients...
EMUC19: Urine biomarkers may detect disease state in NMIBC
The Scientific Programme of the EMUC congress is well-known for its broad coverage of relevant and current updates on genitourinary (GU) malignancies. The upcoming 11th European Multidisciplinary Congress on Urological Cancers (EMUC19) will be no different. One of its...
Minsk first-time host to state-of-the-art Baltic meeting
Minsk will host the 7th Baltic meeting (Baltic20) in conjunction with the EAU which is a first for the Belarusian capital. Scheduled for May 22-23, 2020, the two-day event will deliver progress updates on the latest research and offer...
Prof. Liatsikos gives preview of surgery-focussed ESUT20
Following a well-attended and innovative meeting in Modena last year, the EAU Section of Uro-Technology (ESUT) has its sights set on Leipzig for 2020. On 23-24 January, ESUT and the German Working Groups of Endourology, Laparoscopy, and Robotic-Assisted Surgery...
Researchers can submit their work for prestigious awards bestowed at EAU20
Quality work can lead to breakthroughs in medicine. The EAU endeavours to optimize medical care. In this spirit, the EAU will bestow awards on members who have published papers with distinguished, innovative findings in peer-reviewed journals. The awards will...
Results of EAU RF PRECISION study lead to changes in international prostate cancer diagnosis guidelines
The PRECISION Trial is a landmark study evaluating MRI and MRI-targeted biopsy compared to standard TRUS biopsy in men with suspected prostate cancer who have not had a biopsy before. The study was published in the New England Journal...
ESUI19: Take part in the evolution of urological imaging
Radioguided surgery as a therapeutic procedure was once deemed improbable until a few years ago when it was already administered in selected centres. The significance and popularity of radioguided surgery are gaining momentum. But as benefits go hand-in-hand with...
ESOU20 to unveil GU fundamentals in Dublin
By Prof. Morgan Rouprêt, ESOU Chairman Expect a wide-range, accurate overview of current novelties in onco-urology at 17th Meeting of the EAU Section of Oncological Urology (ESOU20). Join us in Dublin, Ireland from 17 to 19 January 2020 for...
EULIS19 to feature updates paramount to clinical practice
Relevant scientific developments in the pathophysiology, diagnosis, metabolic evaluation, medical and surgical treatment of stone disease will take centre stage at the upcoming 5th Meeting of the EAU Section of Urolithiasis (EULIS19). The best in the field – internationally-renowned...
PCa19: Two days of total immersion in all the latest treatment options for prostate cancer
Participants of PCa19 can expect two days of immersion in all the latest treatment options for prostate cancer, says Prof. Steven Joniau (Leuven, BE), member of the PCa19 Scientific Committee and one of the faculty members. Now in its...
Survey reveals low levels of awareness in men about prostate health and function
Awareness of prostate health is alarmingly low in men over 50, a new survey commissioned by the European Association of Urology (EAU) has revealed, despite the fact that at the age of 60 and over, 40 percent of men suffer from an enlarged...